ClearPoint Neuro (CLPT) Operating Income (2011 - 2026)

ClearPoint Neuro has disclosed Operating Income across 15 years of filings, most recently posting -$8.5 million for Q1 2026.

• Operating Income for Q1 2026 came in at -$8.5 million, down 37.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.5 million (down 22.13% YoY), and the FY2025 annual result was -$24.2 million, down 22.45% from the prior year.
• Operating Income came in at -$8.5 million for Q1 2026 at ClearPoint Neuro, down from -$7.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$3.8 million in Q3 2022 to a low of -$8.5 million in Q1 2026.
• The 5-year median for Operating Income is -$5.2 million (2024), against an average of -$5.4 million.
• Across the five-year window, Operating Income tumbled 77.17% in 2022 and soared 33.75% in 2024, its largest moves.
• ClearPoint Neuro's Operating Income stood at -$4.5 million in 2022, then retreated by 5.3% to -$4.7 million in 2023, then fell by 19.76% to -$5.6 million in 2024, then declined by 25.0% to -$7.0 million in 2025, then fell by 20.34% to -$8.5 million in 2026.
• The last three Operating Income figures came in at -$8.5 million (Q1 2026), -$7.0 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.